HOME >> BIOLOGY >> NEWS
'Crack babies' do better when placed with non-family caregivers

Ever since the epidemic of cocaine and crack use that began in the 1980s, researchers and doctors have been concerned about the development of children born to women who used cocaine during their pregnancy.

Initially, research focused on the potential negative impacts of the drug itself, treating other factors associated with maternal drug use as interfering. However, as researchers accumulated more information, many concluded that focusing on the direct effect of the drug didn't provide a complete picture. In fact, in a letter to the editor of The New York Times on Nov. 28, 2003, 28 leading researchers in the field questioned whether the widely reported "crack baby" syndrome even exists.

In contrast to the lack of evidence regarding the toxic nature of cocaine itself on the developing fetus, the negative effect of cocaine use on the quality of care parents provide to their young children has been consistently documented. Thus, we studied how the type of care provided to toddlers who experienced prenatal cocaine exposure affected their development.

We followed 83 cocaine-exposed and 63 non-exposed children and their caregivers from birth until the children turned 2. By that age, 49 of the cocaine-exposed children remained with their parents while 34 were cared for by other adults. About half of the 34 children in non-parental care were cared for by relatives (kin care) and the rest by unrelated individuals.

We found that prenatal drug exposure was not directly related to the children's developmental outcome at age 2. However, we found that children in non-parental care, especially those in the care of people who were not relatives, had better environments than those cared for by their parents and performed better in several developmental areas.

This improved performance existed despite the fact that these children experienced more problems at birth than the children who remained with their mothers, including prematurit
'"/>

Contact: Karen Melnyk
kmelnyk@apa.org
202-336-5926
Society for Research in Child Development
16-Jul-2004


Page: 1 2

Related biology news :

1. UK study shows breast-feeding increases babies IQ
2. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
3. Microbes eat their way to better concrete
4. Computer database being developed at Temple will allow for better inventory of chemicals
5. New and better drugs for tuberculosis goal of UH professor
6. Ants protect plants better when jacked up on nectar
7. The blind really do hear better
8. Microarrays, key genome expression trackers, work better when probes are sequence-verified
9. Researchers develop better understanding of immune response to viral infection
10. A better way to copy DNA
11. Gene profiles could improve acute leukemia diagnosis and lead to better treatments

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Crack babies better when placed with non family caregivers

(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: